SCM Lifescience

About:

SCM Lifescience is a biotechnology company established with the vision of developing treatment options for difficult to treat diseases

Website: http://scmlifescience.com

Top Investors: Shinhan Venture Investment, DS Asset Management, Dayli Partners, Neoplux

Description:

SCM Lifescience was established in 2014 with the vision of 'developing treatment options for difficult to treat diseases to provide a new source of hope for patients and contribute to the welfare of humanity as a whole' using proprietary stem cell isolation technology and stem cell production technology.

Total Funding Amount:

$35M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Incheon, Inch'on-jikhalsi, South Korea

Founded Date:

2014-01-01

Contact Email:

scm-ir(AT)scmlifescience.com

Founders:

Sun U. Song

Number of Employees:

51-100

Last Funding Date:

2018-09-07

IPO Status:

Private

Industries: